

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 6.89364557 |
| 2 | oxidative demethylation (GO:0070989) | 5.53755159 |
| 3 | alkaloid metabolic process (GO:0009820) | 5.41666783 |
| 4 | dicarboxylic acid catabolic process (GO:0043649) | 5.40305402 |
| 5 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.38516470 |
| 6 | ATP synthesis coupled proton transport (GO:0015986) | 5.07435166 |
| 7 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.07435166 |
| 8 | inositol phosphate-mediated signaling (GO:0048016) | 4.96977681 |
| 9 | neurofilament cytoskeleton organization (GO:0060052) | 4.86997231 |
| 10 | protein polyglutamylation (GO:0018095) | 4.48676640 |
| 11 | DNA damage response, detection of DNA damage (GO:0042769) | 4.33485564 |
| 12 | response to pheromone (GO:0019236) | 4.31979712 |
| 13 | drug catabolic process (GO:0042737) | 4.17291475 |
| 14 | negative regulation of norepinephrine secretion (GO:0010700) | 4.16668103 |
| 15 | protein complex biogenesis (GO:0070271) | 4.16624834 |
| 16 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 4.02755063 |
| 17 | axoneme assembly (GO:0035082) | 3.90936687 |
| 18 | negative regulation of heart rate (GO:0010459) | 3.87821009 |
| 19 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.81227236 |
| 20 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.81227236 |
| 21 | retinal cone cell development (GO:0046549) | 3.80437630 |
| 22 | regulation of uterine smooth muscle contraction (GO:0070472) | 3.72217852 |
| 23 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.67706649 |
| 24 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.51973981 |
| 25 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.51829124 |
| 26 | respiratory electron transport chain (GO:0022904) | 3.50129961 |
| 27 | hydrogen ion transmembrane transport (GO:1902600) | 3.45405357 |
| 28 | electron transport chain (GO:0022900) | 3.43352135 |
| 29 | cornea development in camera-type eye (GO:0061303) | 3.41926265 |
| 30 | neutrophil mediated immunity (GO:0002446) | 3.41497702 |
| 31 | protein neddylation (GO:0045116) | 3.29060037 |
| 32 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 3.27694730 |
| 33 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24601523 |
| 34 | negative regulation of adenylate cyclase activity (GO:0007194) | 3.23744830 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.20671506 |
| 36 | terpenoid biosynthetic process (GO:0016114) | 3.19953592 |
| 37 | proton transport (GO:0015992) | 3.16745140 |
| 38 | ATP biosynthetic process (GO:0006754) | 3.15479245 |
| 39 | hydrogen transport (GO:0006818) | 3.10108461 |
| 40 | regulation of cellular respiration (GO:0043457) | 3.08868784 |
| 41 | cell proliferation in forebrain (GO:0021846) | 3.08495036 |
| 42 | negative regulation of cyclase activity (GO:0031280) | 3.06195357 |
| 43 | protein localization to cilium (GO:0061512) | 3.03757574 |
| 44 | retinal ganglion cell axon guidance (GO:0031290) | 3.02032586 |
| 45 | negative regulation of lyase activity (GO:0051350) | 3.01918226 |
| 46 | negative regulation of catecholamine secretion (GO:0033604) | 3.01251513 |
| 47 | ubiquinone biosynthetic process (GO:0006744) | 3.00110727 |
| 48 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.99778170 |
| 49 | ubiquinone metabolic process (GO:0006743) | 2.98341935 |
| 50 | negative regulation of meiotic cell cycle (GO:0051447) | 2.97670312 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.96838439 |
| 52 | peroxisome fission (GO:0016559) | 2.94852379 |
| 53 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.94507498 |
| 54 | myeloid leukocyte mediated immunity (GO:0002444) | 2.94061747 |
| 55 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.92436044 |
| 56 | DNA double-strand break processing (GO:0000729) | 2.91422479 |
| 57 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88012713 |
| 58 | regulation of meiosis I (GO:0060631) | 2.87472247 |
| 59 | synaptic transmission, cholinergic (GO:0007271) | 2.87391677 |
| 60 | receptor recycling (GO:0001881) | 2.86990881 |
| 61 | exploration behavior (GO:0035640) | 2.80601150 |
| 62 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.78833851 |
| 63 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.78833851 |
| 64 | nonmotile primary cilium assembly (GO:0035058) | 2.75857206 |
| 65 | response to redox state (GO:0051775) | 2.71765852 |
| 66 | circadian sleep/wake cycle process (GO:0022410) | 2.68432867 |
| 67 | short-term memory (GO:0007614) | 2.68023304 |
| 68 | detection of calcium ion (GO:0005513) | 2.66629475 |
| 69 | primary amino compound metabolic process (GO:1901160) | 2.64088109 |
| 70 | protein-cofactor linkage (GO:0018065) | 2.63237939 |
| 71 | isoprenoid biosynthetic process (GO:0008299) | 2.62380508 |
| 72 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.62210733 |
| 73 | activation of protein kinase B activity (GO:0032148) | 2.62163109 |
| 74 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.59286337 |
| 75 | NADH dehydrogenase complex assembly (GO:0010257) | 2.59286337 |
| 76 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.59286337 |
| 77 | artery smooth muscle contraction (GO:0014824) | 2.57587935 |
| 78 | negative regulation of cAMP biosynthetic process (GO:0030818) | 2.56424502 |
| 79 | diterpenoid biosynthetic process (GO:0016102) | 2.55845826 |
| 80 | genetic imprinting (GO:0071514) | 2.55696769 |
| 81 | DNA methylation involved in gamete generation (GO:0043046) | 2.55369646 |
| 82 | protein heterotetramerization (GO:0051290) | 2.53483644 |
| 83 | positive regulation of potassium ion transport (GO:0043268) | 2.53231853 |
| 84 | 4-hydroxyproline metabolic process (GO:0019471) | 2.52259687 |
| 85 | GTP biosynthetic process (GO:0006183) | 2.50058100 |
| 86 | regulation of axon regeneration (GO:0048679) | 2.49124994 |
| 87 | regulation of neuron projection regeneration (GO:0070570) | 2.49124994 |
| 88 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.49102476 |
| 89 | fear response (GO:0042596) | 2.49077572 |
| 90 | negative regulation of purine nucleotide biosynthetic process (GO:1900372) | 2.45978110 |
| 91 | negative regulation of nucleotide biosynthetic process (GO:0030809) | 2.45978110 |
| 92 | negative regulation of cyclic nucleotide biosynthetic process (GO:0030803) | 2.45366157 |
| 93 | energy homeostasis (GO:0097009) | 2.45084679 |
| 94 | calcium ion import (GO:0070509) | 2.44980494 |
| 95 | amino acid salvage (GO:0043102) | 2.44864013 |
| 96 | L-methionine salvage (GO:0071267) | 2.44864013 |
| 97 | L-methionine biosynthetic process (GO:0071265) | 2.44864013 |
| 98 | negative regulation of cAMP metabolic process (GO:0030815) | 2.42371085 |
| 99 | adrenergic receptor signaling pathway (GO:0071875) | 2.40383358 |
| 100 | sterol biosynthetic process (GO:0016126) | 2.40272754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.32911231 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.49057652 |
| 3 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.05474263 |
| 4 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.98091630 |
| 5 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.74113737 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 2.72774273 |
| 7 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.65116970 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59156141 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.39005819 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.29182777 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.26641259 |
| 12 | TP53_22573176_ChIP-Seq_HFKS_Human | 2.14449242 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.06041467 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.00855119 |
| 15 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.96223260 |
| 16 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.80993449 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.80443200 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.77957495 |
| 19 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.66678249 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.65192203 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64741419 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.63821745 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.59709227 |
| 24 | FUS_26573619_Chip-Seq_HEK293_Human | 1.54098715 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53082475 |
| 26 | P300_19829295_ChIP-Seq_ESCs_Human | 1.52661863 |
| 27 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.49842541 |
| 28 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.49313373 |
| 29 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.48086314 |
| 30 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.46010622 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.45609703 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.44991084 |
| 33 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.44831438 |
| 34 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.44307404 |
| 35 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.43674235 |
| 36 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.43270198 |
| 37 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.42932342 |
| 38 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.42932342 |
| 39 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.39322817 |
| 40 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37738539 |
| 41 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.35031759 |
| 42 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34438745 |
| 43 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32872400 |
| 44 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.32061872 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31816183 |
| 46 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31598380 |
| 47 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.30241804 |
| 48 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.29754563 |
| 49 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.29452793 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28638481 |
| 51 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.28513111 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.28390276 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.26589276 |
| 54 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21501966 |
| 55 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.20746382 |
| 56 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20417574 |
| 57 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.19852011 |
| 58 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.16515795 |
| 59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16203548 |
| 60 | AR_20517297_ChIP-Seq_VCAP_Human | 1.15314916 |
| 61 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15101162 |
| 62 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.15046650 |
| 63 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14792557 |
| 64 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.12838508 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12630171 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.11991880 |
| 67 | TCF4_23295773_ChIP-Seq_U87_Human | 1.11933297 |
| 68 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11672514 |
| 69 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11086050 |
| 70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10610394 |
| 71 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.09795909 |
| 72 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.09377019 |
| 73 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.06601602 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.06469130 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.06469130 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06359879 |
| 77 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06359879 |
| 78 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05150233 |
| 79 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.03832559 |
| 80 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02849479 |
| 81 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02136611 |
| 82 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.00732620 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.00715956 |
| 84 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.00511463 |
| 85 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.99584547 |
| 86 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.99315740 |
| 87 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99024289 |
| 88 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.98938335 |
| 89 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.98820956 |
| 90 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94739379 |
| 91 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.94739379 |
| 92 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94648104 |
| 93 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94477398 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.93801677 |
| 95 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.93767934 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.93389097 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93131357 |
| 98 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.92839978 |
| 99 | NCOR_22424771_ChIP-Seq_293T_Human | 0.92309049 |
| 100 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.92151781 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.83278540 |
| 2 | MP0003195_calcinosis | 5.11382507 |
| 3 | MP0002163_abnormal_gland_morphology | 4.08903998 |
| 4 | MP0003787_abnormal_imprinting | 4.01353094 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 3.30813696 |
| 6 | MP0000569_abnormal_digit_pigmentation | 2.82890022 |
| 7 | MP0001986_abnormal_taste_sensitivity | 2.71461477 |
| 8 | MP0003123_paternal_imprinting | 2.67756243 |
| 9 | MP0006292_abnormal_olfactory_placode | 2.66727006 |
| 10 | MP0009046_muscle_twitch | 2.63034333 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.62324545 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 2.59413517 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.47924005 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.47832892 |
| 15 | MP0001984_abnormal_olfaction | 2.19607099 |
| 16 | MP0001440_abnormal_grooming_behavior | 2.08817679 |
| 17 | MP0006082_CNS_inflammation | 2.07453146 |
| 18 | MP0003122_maternal_imprinting | 2.06620634 |
| 19 | MP0002272_abnormal_nervous_system | 2.01448460 |
| 20 | MP0001970_abnormal_pain_threshold | 1.83171987 |
| 21 | MP0003121_genomic_imprinting | 1.69084400 |
| 22 | MP0009745_abnormal_behavioral_response | 1.65727586 |
| 23 | MP0004142_abnormal_muscle_tone | 1.64073061 |
| 24 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56544597 |
| 25 | MP0002837_dystrophic_cardiac_calcinosis | 1.53728329 |
| 26 | MP0002572_abnormal_emotion/affect_behav | 1.51307401 |
| 27 | MP0003635_abnormal_synaptic_transmissio | 1.46474289 |
| 28 | MP0002234_abnormal_pharynx_morphology | 1.45506690 |
| 29 | MP0003011_delayed_dark_adaptation | 1.45486824 |
| 30 | MP0008872_abnormal_physiological_respon | 1.42906100 |
| 31 | MP0004043_abnormal_pH_regulation | 1.42383561 |
| 32 | MP0005645_abnormal_hypothalamus_physiol | 1.40681106 |
| 33 | MP0000013_abnormal_adipose_tissue | 1.38926666 |
| 34 | MP0002734_abnormal_mechanical_nocicepti | 1.35350451 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.34468332 |
| 36 | MP0002063_abnormal_learning/memory/cond | 1.33334729 |
| 37 | MP0004742_abnormal_vestibular_system | 1.26687463 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.25196873 |
| 39 | MP0002064_seizures | 1.24352091 |
| 40 | MP0010386_abnormal_urinary_bladder | 1.22213735 |
| 41 | MP0003136_yellow_coat_color | 1.22192251 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.22037957 |
| 43 | MP0005332_abnormal_amino_acid | 1.22012387 |
| 44 | MP0003186_abnormal_redox_activity | 1.21119518 |
| 45 | MP0001919_abnormal_reproductive_system | 1.19721260 |
| 46 | MP0006035_abnormal_mitochondrial_morpho | 1.19111165 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.17048094 |
| 48 | MP0003880_abnormal_central_pattern | 1.14585207 |
| 49 | MP0002733_abnormal_thermal_nociception | 1.12093354 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.10281590 |
| 51 | MP0002653_abnormal_ependyma_morphology | 1.10194865 |
| 52 | MP0000631_abnormal_neuroendocrine_gland | 1.09437049 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.06476778 |
| 54 | MP0004924_abnormal_behavior | 1.06476778 |
| 55 | MP0002067_abnormal_sensory_capabilities | 1.04207495 |
| 56 | MP0002909_abnormal_adrenal_gland | 0.99492072 |
| 57 | MP0004484_altered_response_of | 0.96119394 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 0.95150802 |
| 59 | MP0003633_abnormal_nervous_system | 0.94495922 |
| 60 | MP0006276_abnormal_autonomic_nervous | 0.92851751 |
| 61 | MP0005646_abnormal_pituitary_gland | 0.91640801 |
| 62 | MP0004085_abnormal_heartbeat | 0.91528176 |
| 63 | MP0001270_distended_abdomen | 0.89243897 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 0.87726227 |
| 65 | MP0000538_abnormal_urinary_bladder | 0.87212843 |
| 66 | MP0006072_abnormal_retinal_apoptosis | 0.87165627 |
| 67 | MP0001756_abnormal_urination | 0.86335884 |
| 68 | MP0001348_abnormal_lacrimal_gland | 0.85435983 |
| 69 | MP0001486_abnormal_startle_reflex | 0.84552214 |
| 70 | MP0000015_abnormal_ear_pigmentation | 0.84342934 |
| 71 | MP0002735_abnormal_chemical_nociception | 0.82562209 |
| 72 | MP0002736_abnormal_nociception_after | 0.80579532 |
| 73 | MP0003879_abnormal_hair_cell | 0.80211711 |
| 74 | MP0004019_abnormal_vitamin_homeostasis | 0.80102609 |
| 75 | MP0005085_abnormal_gallbladder_physiolo | 0.79529725 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.79196359 |
| 77 | MP0009379_abnormal_foot_pigmentation | 0.79016286 |
| 78 | MP0005389_reproductive_system_phenotype | 0.77536740 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 0.77136240 |
| 80 | MP0002160_abnormal_reproductive_system | 0.75536794 |
| 81 | MP0000639_abnormal_adrenal_gland | 0.74951862 |
| 82 | MP0002184_abnormal_innervation | 0.74428494 |
| 83 | MP0001765_abnormal_ion_homeostasis | 0.73790841 |
| 84 | MP0001529_abnormal_vocalization | 0.70714467 |
| 85 | MP0000685_abnormal_immune_system | 0.70650458 |
| 86 | MP0003631_nervous_system_phenotype | 0.70443003 |
| 87 | MP0002938_white_spotting | 0.69004799 |
| 88 | MP0010329_abnormal_lipoprotein_level | 0.68500172 |
| 89 | MP0003646_muscle_fatigue | 0.68357185 |
| 90 | MP0005253_abnormal_eye_physiology | 0.67579416 |
| 91 | MP0004885_abnormal_endolymph | 0.67525848 |
| 92 | MP0002229_neurodegeneration | 0.65794592 |
| 93 | MP0002882_abnormal_neuron_morphology | 0.65777400 |
| 94 | MP0001905_abnormal_dopamine_level | 0.64404705 |
| 95 | MP0004811_abnormal_neuron_physiology | 0.63984534 |
| 96 | MP0004859_abnormal_synaptic_plasticity | 0.60665793 |
| 97 | MP0005174_abnormal_tail_pigmentation | 0.60543520 |
| 98 | MP0003938_abnormal_ear_development | 0.59690423 |
| 99 | MP0000955_abnormal_spinal_cord | 0.58582102 |
| 100 | MP0008789_abnormal_olfactory_epithelium | 0.56919948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Broad alveolar ridges (HP:0000187) | 5.81655165 |
| 2 | Myokymia (HP:0002411) | 5.59736846 |
| 3 | Limb dystonia (HP:0002451) | 4.92861873 |
| 4 | Febrile seizures (HP:0002373) | 3.76392288 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.67694243 |
| 6 | Action tremor (HP:0002345) | 3.64135785 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 3.49936934 |
| 8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.43908132 |
| 9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.43908132 |
| 10 | Atonic seizures (HP:0010819) | 3.34729009 |
| 11 | Acute necrotizing encephalopathy (HP:0006965) | 3.26175826 |
| 12 | Type II lissencephaly (HP:0007260) | 3.23543498 |
| 13 | Focal seizures (HP:0007359) | 3.21987291 |
| 14 | Neoplasm of the adrenal cortex (HP:0100641) | 3.06351117 |
| 15 | Mitochondrial inheritance (HP:0001427) | 3.03796104 |
| 16 | Increased CSF lactate (HP:0002490) | 3.02680326 |
| 17 | Hepatic necrosis (HP:0002605) | 2.91255813 |
| 18 | Abnormality of the alveolar ridges (HP:0006477) | 2.86954410 |
| 19 | Dysdiadochokinesis (HP:0002075) | 2.83717331 |
| 20 | Abnormal tarsal ossification (HP:0008369) | 2.81827658 |
| 21 | Hepatocellular necrosis (HP:0001404) | 2.81243365 |
| 22 | Stenosis of the external auditory canal (HP:0000402) | 2.78576942 |
| 23 | Neonatal hypoglycemia (HP:0001998) | 2.77620889 |
| 24 | Acute encephalopathy (HP:0006846) | 2.77237565 |
| 25 | Abnormality of the corticospinal tract (HP:0002492) | 2.76564392 |
| 26 | Medial flaring of the eyebrow (HP:0010747) | 2.75708662 |
| 27 | Lissencephaly (HP:0001339) | 2.72377425 |
| 28 | Abnormal pancreas size (HP:0012094) | 2.71370889 |
| 29 | Focal motor seizures (HP:0011153) | 2.71062215 |
| 30 | Progressive macrocephaly (HP:0004481) | 2.62255212 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.61974886 |
| 32 | Severe visual impairment (HP:0001141) | 2.57068942 |
| 33 | Renal cortical cysts (HP:0000803) | 2.50776368 |
| 34 | Pancreatic cysts (HP:0001737) | 2.42644029 |
| 35 | Abnormality of midbrain morphology (HP:0002418) | 2.38449836 |
| 36 | Molar tooth sign on MRI (HP:0002419) | 2.38449836 |
| 37 | Absence seizures (HP:0002121) | 2.37822479 |
| 38 | X-linked dominant inheritance (HP:0001423) | 2.37492102 |
| 39 | Abnormality of magnesium homeostasis (HP:0004921) | 2.37042004 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.36692702 |
| 41 | Renal dysplasia (HP:0000110) | 2.36601931 |
| 42 | Retinal dysplasia (HP:0007973) | 2.34779900 |
| 43 | Hypomagnesemia (HP:0002917) | 2.32725552 |
| 44 | Broad-based gait (HP:0002136) | 2.31803113 |
| 45 | EEG with generalized epileptiform discharges (HP:0011198) | 2.29837869 |
| 46 | Hypsarrhythmia (HP:0002521) | 2.28937059 |
| 47 | Epileptiform EEG discharges (HP:0011182) | 2.27687704 |
| 48 | Abnormality of alanine metabolism (HP:0010916) | 2.26556084 |
| 49 | Hyperalaninemia (HP:0003348) | 2.26556084 |
| 50 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.26556084 |
| 51 | Epileptic encephalopathy (HP:0200134) | 2.26374155 |
| 52 | Generalized aminoaciduria (HP:0002909) | 2.23389565 |
| 53 | Congenital, generalized hypertrichosis (HP:0004540) | 2.22271670 |
| 54 | Increased serum lactate (HP:0002151) | 2.18379536 |
| 55 | Parakeratosis (HP:0001036) | 2.17607005 |
| 56 | Optic disc pallor (HP:0000543) | 2.16214616 |
| 57 | Spastic tetraplegia (HP:0002510) | 2.15734439 |
| 58 | Gaze-evoked nystagmus (HP:0000640) | 2.14461953 |
| 59 | Diastasis recti (HP:0001540) | 2.14235996 |
| 60 | Large eyes (HP:0001090) | 2.12030082 |
| 61 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.10432821 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.10432821 |
| 63 | Increased muscle lipid content (HP:0009058) | 2.10228265 |
| 64 | Increased hepatocellular lipid droplets (HP:0006565) | 2.08359520 |
| 65 | Hepatoblastoma (HP:0002884) | 2.07828431 |
| 66 | Pachygyria (HP:0001302) | 2.04819452 |
| 67 | Abnormality of renal resorption (HP:0011038) | 2.04281161 |
| 68 | Adrenal hypoplasia (HP:0000835) | 2.03227672 |
| 69 | Glycosuria (HP:0003076) | 2.03203738 |
| 70 | Abnormality of urine glucose concentration (HP:0011016) | 2.03203738 |
| 71 | Tetraplegia (HP:0002445) | 2.02845855 |
| 72 | Neoplasm of the adrenal gland (HP:0100631) | 2.02273956 |
| 73 | Metaphyseal dysplasia (HP:0100255) | 2.01506788 |
| 74 | Erythroderma (HP:0001019) | 2.01189123 |
| 75 | Gait imbalance (HP:0002141) | 2.00904827 |
| 76 | Drooling (HP:0002307) | 1.98414435 |
| 77 | Mutism (HP:0002300) | 1.97924548 |
| 78 | Nephronophthisis (HP:0000090) | 1.97401148 |
| 79 | Lipid accumulation in hepatocytes (HP:0006561) | 1.95762476 |
| 80 | Abnormality of the renal cortex (HP:0011035) | 1.95328137 |
| 81 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.93319611 |
| 82 | Dialeptic seizures (HP:0011146) | 1.92612937 |
| 83 | Renal Fanconi syndrome (HP:0001994) | 1.91946155 |
| 84 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.91235634 |
| 85 | Severe muscular hypotonia (HP:0006829) | 1.91015520 |
| 86 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.88608320 |
| 87 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.88455953 |
| 88 | Hypothermia (HP:0002045) | 1.88088273 |
| 89 | Polydipsia (HP:0001959) | 1.85674074 |
| 90 | Abnormal drinking behavior (HP:0030082) | 1.85674074 |
| 91 | Congenital stationary night blindness (HP:0007642) | 1.83319394 |
| 92 | Overlapping toe (HP:0001845) | 1.82525154 |
| 93 | Exocrine pancreatic insufficiency (HP:0001738) | 1.82510624 |
| 94 | Cerebellar dysplasia (HP:0007033) | 1.81951597 |
| 95 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.81276122 |
| 96 | Excessive salivation (HP:0003781) | 1.81128492 |
| 97 | Lactic acidosis (HP:0003128) | 1.80295635 |
| 98 | Intellectual disability, moderate (HP:0002342) | 1.78247314 |
| 99 | Type I transferrin isoform profile (HP:0003642) | 1.77328648 |
| 100 | Congenital primary aphakia (HP:0007707) | 1.76466300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRKD3 | 7.22772481 |
| 2 | BMPR1B | 4.22162123 |
| 3 | MAP3K12 | 3.81622019 |
| 4 | CASK | 3.63177258 |
| 5 | CAMKK2 | 3.42137918 |
| 6 | CDK8 | 3.09736509 |
| 7 | BCR | 2.49443632 |
| 8 | ZAK | 2.00729797 |
| 9 | LIMK1 | 1.97136039 |
| 10 | TNIK | 1.88914645 |
| 11 | TESK1 | 1.80346292 |
| 12 | GRK1 | 1.79720332 |
| 13 | FRK | 1.74150635 |
| 14 | MAP4K2 | 1.69546624 |
| 15 | PDK2 | 1.64161812 |
| 16 | ADRBK2 | 1.49600836 |
| 17 | TXK | 1.44038781 |
| 18 | FLT3 | 1.34120893 |
| 19 | MYLK | 1.32904623 |
| 20 | PHKG2 | 1.32795003 |
| 21 | PHKG1 | 1.32795003 |
| 22 | TGFBR1 | 1.26509841 |
| 23 | CDK19 | 1.25215044 |
| 24 | PKN2 | 1.24985639 |
| 25 | WNK4 | 1.23108496 |
| 26 | ADRBK1 | 1.20946282 |
| 27 | PLK2 | 1.17197111 |
| 28 | TIE1 | 1.01266106 |
| 29 | MARK1 | 1.00692569 |
| 30 | MST4 | 0.94146095 |
| 31 | PRKCE | 0.93001543 |
| 32 | PKN1 | 0.89543084 |
| 33 | PINK1 | 0.86279224 |
| 34 | CAMK2A | 0.86141870 |
| 35 | NUAK1 | 0.85898672 |
| 36 | TAOK3 | 0.84411716 |
| 37 | CSNK1G3 | 0.83031509 |
| 38 | DYRK2 | 0.81994386 |
| 39 | PRKCG | 0.79765497 |
| 40 | EIF2AK3 | 0.76548653 |
| 41 | ERN1 | 0.75709444 |
| 42 | PNCK | 0.75422227 |
| 43 | CSNK1G2 | 0.75080766 |
| 44 | EIF2AK1 | 0.74180865 |
| 45 | OXSR1 | 0.72941096 |
| 46 | CAMKK1 | 0.69951871 |
| 47 | PAK4 | 0.69152273 |
| 48 | DAPK3 | 0.67999824 |
| 49 | CSNK1A1L | 0.66137459 |
| 50 | PRKG1 | 0.61270931 |
| 51 | TRIM28 | 0.60519448 |
| 52 | ITK | 0.59716296 |
| 53 | ROCK1 | 0.59143788 |
| 54 | AKT2 | 0.58189864 |
| 55 | MST1R | 0.57023974 |
| 56 | MINK1 | 0.56572553 |
| 57 | CSNK1G1 | 0.56331421 |
| 58 | PAK1 | 0.55291782 |
| 59 | ARAF | 0.55216199 |
| 60 | MAPK13 | 0.54698912 |
| 61 | WNK3 | 0.51799797 |
| 62 | PRKCI | 0.49723985 |
| 63 | PAK3 | 0.49268515 |
| 64 | ABL2 | 0.47605131 |
| 65 | INSRR | 0.47444172 |
| 66 | PRKCA | 0.47257256 |
| 67 | IRAK3 | 0.46000487 |
| 68 | GRK5 | 0.44584831 |
| 69 | RPS6KA2 | 0.44534946 |
| 70 | ILK | 0.42863948 |
| 71 | UHMK1 | 0.41267323 |
| 72 | PRKACA | 0.40891853 |
| 73 | CDK9 | 0.40312664 |
| 74 | PRKCD | 0.40220962 |
| 75 | DAPK2 | 0.40091062 |
| 76 | CAMK1G | 0.40037837 |
| 77 | CHEK2 | 0.39993384 |
| 78 | EPHB2 | 0.38939590 |
| 79 | GRK6 | 0.38830156 |
| 80 | CSNK1A1 | 0.38006689 |
| 81 | CAMK4 | 0.37682296 |
| 82 | WNK1 | 0.37051323 |
| 83 | HIPK2 | 0.35394317 |
| 84 | PTK2 | 0.34987812 |
| 85 | CDK5 | 0.34806559 |
| 86 | CLK1 | 0.34546914 |
| 87 | CAMK1 | 0.34429798 |
| 88 | MAP3K4 | 0.32366153 |
| 89 | CSNK1E | 0.31974845 |
| 90 | MKNK2 | 0.31351297 |
| 91 | STK38L | 0.31180023 |
| 92 | TAF1 | 0.31094859 |
| 93 | ERBB2 | 0.30690988 |
| 94 | LATS1 | 0.30635911 |
| 95 | CAMK2D | 0.28770974 |
| 96 | ROCK2 | 0.28441920 |
| 97 | NTRK2 | 0.27437366 |
| 98 | PIK3CA | 0.26627887 |
| 99 | VRK1 | 0.26215467 |
| 100 | RPS6KA6 | 0.25527828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.88872071 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66872715 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.48186363 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.43213952 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.89614148 |
| 6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.81986878 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.60719671 |
| 8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.43408977 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.13053014 |
| 10 | Huntingtons disease_Homo sapiens_hsa05016 | 1.99327560 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.94090558 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.84318234 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 1.84288974 |
| 14 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.83359760 |
| 15 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67901264 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.66999367 |
| 17 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.66094113 |
| 18 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63243172 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.61777037 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.59557908 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.58213433 |
| 22 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.55270317 |
| 23 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.54422914 |
| 24 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.53150501 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.45340196 |
| 26 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.44782425 |
| 27 | Ribosome_Homo sapiens_hsa03010 | 1.44175385 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.36768909 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33373449 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.31722189 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.29104060 |
| 32 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.24461780 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.21886028 |
| 34 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.16055964 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12963244 |
| 36 | Insulin secretion_Homo sapiens_hsa04911 | 1.11769781 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11598602 |
| 38 | Cocaine addiction_Homo sapiens_hsa05030 | 1.07392066 |
| 39 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07121397 |
| 40 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01625713 |
| 41 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.01055683 |
| 42 | Renin secretion_Homo sapiens_hsa04924 | 1.00208793 |
| 43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.97198870 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95513489 |
| 45 | Proteasome_Homo sapiens_hsa03050 | 0.94492218 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 0.94475555 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.92800728 |
| 48 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92579681 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.91597830 |
| 50 | Salivary secretion_Homo sapiens_hsa04970 | 0.91176592 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.87760429 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87042842 |
| 53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82785587 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79405663 |
| 55 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73724242 |
| 56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71632165 |
| 57 | Phototransduction_Homo sapiens_hsa04744 | 0.71550755 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70800311 |
| 59 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70285036 |
| 60 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69502005 |
| 61 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68730735 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.68606626 |
| 63 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.67807792 |
| 64 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61762086 |
| 65 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59357963 |
| 66 | RNA polymerase_Homo sapiens_hsa03020 | 0.56567603 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.56460506 |
| 68 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.56404216 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.55677368 |
| 70 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.54609942 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54582358 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.53007750 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53001258 |
| 74 | RNA degradation_Homo sapiens_hsa03018 | 0.52317861 |
| 75 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47861246 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44361134 |
| 77 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43854627 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43622969 |
| 79 | Gap junction_Homo sapiens_hsa04540 | 0.42706790 |
| 80 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42352437 |
| 81 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41484545 |
| 82 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41052897 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39224731 |
| 84 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.38183350 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.36308167 |
| 86 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36154219 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.35322039 |
| 88 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.35237348 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.34374782 |
| 90 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34298174 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.34089838 |
| 92 | Basal transcription factors_Homo sapiens_hsa03022 | 0.32605699 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31868535 |
| 94 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31504356 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.30362640 |
| 96 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.29064632 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.28175115 |
| 98 | Tight junction_Homo sapiens_hsa04530 | 0.27877006 |
| 99 | Asthma_Homo sapiens_hsa05310 | 0.27337463 |
| 100 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.27241046 |

